Bullish Moving Averages
15
Bearish Moving Averages
1
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
1803.00Today’s High
1868.8052W low
1042.0052W High
2194.00Open Price
1815.00Prev. Close
1833.3000Volume
303428.00Value
558231663.00Fundamentals
Market Cap
30310.20
Price to Earnings
39.20
Price to Book Value
3.50
Dividend Yield
0.00
PE to Growth
-35.70
Op Revenue TTM
5664.72
Net Profit TTM
772.46
Cash From Operating Activity
996.80
Return on Equity %
8.85
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
57.1
Week
65.2
Month
83.7
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1837.17
PIVOT
First Resistance
1871.33
Second Resistance
1902.92
Third Resistance
1937.08
First Support
1805.58
Second Support
1771.42
Third Support
1739.83
Relative Strength Index
54.5
Money Flow Index
37.42
MACD
-0.33
MACD Signal
1.97
Average True Range
46.99
Average Directional Index
21.32
Rate of Change (21)
0.36
Rate of Change (125)
-9.42
Commodity Channel Index
7.4
Williams %R
-35.6
BETA
1 Month
0.63
3 Month
0.61
1 Year
0.56
3 Year
0.2
PRICE CHANGE ANALYSIS
↑ 1.23%
1 Week
Low
High
1803
1868.75
↑ 2.75%
1 Month
Low
High
1722.95
1914.75
↑ 3.64%
3 Months
Low
High
1654.5
1989.9
↓ -6.86%
6 Months
Low
High
1654.5
2194
↑ 74.91%
1 Year
Low
High
1042
2194
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1221.79 | 1141.25 | 1051.78 | 919.28 | 824.36 | 987.41 | 1113.93 | 931.29 | 1168.25 | 1108.99 | 1131.67 | |
| Operating Expenses Qtr | 742.00 | 728.37 | 663.57 | 624.71 | 616.27 | 641.94 | 753.07 | 586.70 | 754.58 | 714.06 | 703.83 | |
| Operating Profit Qtr | 432.83 | 369.49 | 347.10 | 259.36 | 169.15 | 283.96 | 295.24 | 270.20 | 348.43 | 349.27 | 376.64 | |
| EBIDT Qtr Cr | 479.79 | 412.88 | 388.21 | 294.57 | 151.63 | 345.47 | 360.86 | 344.60 | 413.67 | 394.94 | 427.84 | |
| Depreciation Qtr | 42.56 | 40.33 | 40.24 | 38.98 | 37.54 | 37.61 | 36.67 | 34.91 | 31.07 | 27.83 | 26.11 | |
| Net Profit Qtr | 321.41 | 276.81 | 257.53 | 187.58 | 79.21 | 227.54 | 239.63 | 229.45 | 285.98 | 273.38 | 302.12 | |
| Basic EPS Qtr | 19.51 | 16.81 | 15.64 | 11.39 | 4.81 | 13.82 | 14.55 | 13.95 | 17.41 | 16.64 | 18.37 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 4334.09 | 3856.99 | 4624.65 | 3597.65 | 2772.41 | |
| Operating Expenses Annual Cr | 2758.65 | 2597.98 | 2890.07 | 2160.61 | 1677.77 | |
| Operating Profit Annual | 1408.78 | 1018.55 | 1510.64 | 1302.27 | 955.47 | |
| Operating Profit Margin Annual % | 32.50 | 26.41 | 32.66 | 36.20 | 34.46 | |
| Total Expenses Annual Cr | 2928.60 | 2752.13 | 3005.61 | 2262.80 | 1779.54 | |
| EBIDT Annual Cr | 1575.45 | 1259.01 | 1734.58 | 1437.04 | 1094.63 | |
| EBIDT Annual margin % | 36.35 | 32.64 | 37.51 | 39.94 | 39.48 | |
| Depreciation | 162.11 | 146.74 | 110.30 | 98.78 | 94.59 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1043.33 | 775.83 | 1212.15 | 997.00 | 772.86 | |
| Net Profit Annual | 1043.33 | 775.83 | 1212.15 | 997.00 | 772.86 | |
| Basic EPS Annual | 63.35 | 47.12 | 73.84 | 63.07 | 49.88 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 8995.29 | 7953.30 | 7158.15 | 5903.28 | 3646.24 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 131.60 | 89.68 | 93.97 | 80.31 | 80.78 | |
| Total Current Liabilities Annual Cr | 414.20 | 730.20 | 581.94 | 512.46 | 359.02 | |
| Total Capital Plus Liabilities Annual Cr | 9541.09 | 8773.18 | 7834.14 | 6496.06 | 4086.04 | |
| Fixed Assets Annual | 1813.53 | 1747.76 | 1692.94 | 1292.04 | 1156.57 | |
| Total Non Current Assets Annual | 4969.76 | 1884.84 | 1989.70 | 1372.99 | 1239.75 | |
| Total Current Assets Annual | 4571.32 | 6888.34 | 5844.44 | 5123.07 | 2846.29 | |
| Total Assets Annual | 9541.09 | 8773.18 | 7834.14 | 6496.06 | 4086.04 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 128.46 | 124.53 | 219.23 | 134.54 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1135.97 | 367.89 | 791.29 | 604.93 | 700.93 | |
| Cash from Investing Activity Annual | -2923.92 | 1208.22 | -1010.23 | -1524.55 | -766.08 | |
| Cash from Financing Annual Activity | -7.40 | 14.92 | 34.90 | 1238.46 | -6.87 | |
| Net Cash Flow Annual | - | 1591.04 | -184.04 | 318.84 | -72.01 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 546.13 | 482.90 | 435.68 | 360.86 | 235.32 | |
| ROE Annual % | 11.59 | 9.75 | 16.93 | 16.88 | 21.19 | |
| ROCE Annual % | 15.48 | 13.82 | 22.39 | 22.36 | 26.83 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 37.80 | 34.81 | 39.41 | 41.49 | 41.56 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1579.60 | 1582.55 | 1426.58 | 1246.23 | 823.95 | 999.80 | 1110.03 | 931.29 | 1168.25 | 1108.99 | 1131.67 | |
| Operating Expenses Qtr | 1178.80 | 1188.77 | 1049.35 | 914.74 | 616.59 | 648.72 | 747.55 | 586.98 | 754.66 | 714.41 | 703.87 | |
| Operating Profit Qtr | 358.65 | 356.39 | 324.08 | 293.95 | 168.42 | 289.57 | 296.85 | 269.92 | 348.36 | 348.91 | 376.60 | |
| EBIDT Qtr Cr | 400.80 | 393.78 | 377.23 | 331.50 | 150.90 | 351.08 | 362.48 | 344.31 | 413.59 | 394.58 | 427.80 | |
| Depreciation Qtr | 92.61 | 105.34 | 81.30 | 65.31 | 37.54 | 37.61 | 36.67 | 34.91 | 31.07 | 27.83 | 26.11 | |
| Net Profit Qtr | 192.42 | 191.86 | 194.08 | 194.10 | 78.68 | 231.95 | 241.24 | 229.17 | 285.90 | 273.03 | 302.08 | |
| Basic EPS Qtr | 11.68 | 11.65 | 11.78 | 11.79 | 4.78 | 14.08 | 14.65 | 13.93 | 17.40 | 16.62 | 18.37 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 5834.96 | 3865.06 | 4624.65 | 3597.65 | 2772.41 | |
| Operating Expenses Annual Cr | 4331.65 | 2599.84 | 2890.56 | 2160.65 | 1677.77 | |
| Operating Profit Annual | 1333.07 | 1024.76 | 1510.15 | 1302.22 | 955.47 | |
| Operating Profit Margin Annual % | 22.85 | 26.51 | 32.65 | 36.20 | 34.46 | |
| Total Expenses Annual Cr | 4702.41 | 2754.02 | 3006.09 | 2262.84 | 1779.54 | |
| EBIDT Annual Cr | 1503.31 | 1265.23 | 1734.09 | 1437.00 | 1094.63 | |
| EBIDT Annual margin % | 25.76 | 32.73 | 37.50 | 39.94 | 39.48 | |
| Depreciation | 344.57 | 146.74 | 110.30 | 98.78 | 94.59 | |
| PAT Before ExtraOrdinary Items Annual Cr | 772.46 | 781.04 | 1211.66 | 996.96 | 772.86 | |
| Net Profit Annual | 772.46 | 781.04 | 1211.66 | 996.96 | 772.86 | |
| Basic EPS Annual | 46.90 | 47.43 | 73.81 | 62.99 | 49.88 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 8723.84 | 7958.72 | 7157.54 | 5903.24 | 3646.24 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 539.04 | 89.68 | 93.97 | 80.31 | 80.78 | |
| Total Current Liabilities Annual Cr | 1398.36 | 729.13 | 582.02 | 512.53 | 359.02 | |
| Total Capital Plus Liabilities Annual Cr | 10661.25 | 8777.53 | 7833.62 | 6496.08 | 4086.04 | |
| Fixed Assets Annual | 3891.41 | 1747.76 | 1692.94 | 1292.04 | 1156.57 | |
| Total Non Current Assets Annual | 5016.09 | 1876.73 | 1981.54 | 1372.44 | 1239.75 | |
| Total Current Assets Annual | 5645.15 | 6900.81 | 5852.08 | 5123.64 | 2846.29 | |
| Total Assets Annual | 10661.25 | 8777.53 | 7833.62 | 6496.08 | 4086.04 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 128.46 | 124.53 | 74.70 | 11.83 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 996.80 | 363.97 | 790.77 | 604.93 | 700.93 | |
| Cash from Investing Activity Annual | -1756.91 | 1208.19 | -1002.62 | -1524.00 | -766.08 | |
| Cash from Financing Annual Activity | -799.42 | 14.92 | 34.90 | 1238.46 | -6.87 | |
| Net Cash Flow Annual | - | 1587.08 | -176.95 | 319.39 | -72.01 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 529.65 | 483.23 | 435.64 | 360.86 | 235.32 | |
| ROE Annual % | 8.85 | 9.81 | 16.92 | 16.88 | 21.19 | |
| ROCE Annual % | 12.50 | 13.89 | 22.39 | 22.36 | 26.83 | |
| Total Debt to Total Equity Annual | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 26.53 | 34.90 | 39.40 | 41.49 | 41.56 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Sbi Large & Midcap Fund | 3.58 | 74537843 | - | - |
| Hdfc Mutual Fund - Hdfc Mid-Cap Opportunities Fund | 3.08 | 74537844 | - | - |
| Icici Prudential Equity & Debt Fund | 1.22 | 74537846 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Fosun Pharma Industrial Pte. Ltd | 57.86 | 74537834 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Mirae Asset Large & Midcap Fund | 6.19 | 74537841 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | 5.53 | 74537842 |
| Sbi Large & Midcap Fund | 3.58 | 74537843 |
| Hdfc Mutual Fund - Hdfc Mid-Cap Opportunities Fund | 3.08 | 74537844 |
| Uti Flexi Cap Fund | 1.26 | 74537845 |
| Icici Prudential Equity & Debt Fund | 1.22 | 74537846 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Rp Advisory Services Private Limited | 3.74 | 74537858 |
| Nicomac Machinery Private Limited | 1.19 | 74537859 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 22, 2024 | Audited Results & Final Dividend | - |
| Feb 14, 2024 | Quarterly Results | - |
| Nov 06, 2023 | Quarterly Results | - |
| Aug 07, 2023 | Quarterly Results | - |
| May 18, 2023 | Audited Results & A.G.M. | - |
| Jan 23, 2023 | Quarterly Results | - |
| Oct 26, 2022 | Quarterly Results | - |
| Jul 20, 2022 | Quarterly Results | - |
| May 19, 2022 | Audited Results | - |
| Jan 21, 2022 | Quarterly Results | - |
| Oct 22, 2021 | Quarterly Results | - |
| Jul 21, 2021 | Quarterly Results | - |
| May 17, 2021 | Audited Results | - |
| Jan 22, 2021 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
28 Jun 2024
Gland Pharma Ltd - 543245 - Closure of Trading Window
Intimation regarding Trading Window Closure of Gland Pharma Limited
26 Jun 2024
Gland Pharma Ltd - 543245 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund
24 Jun 2024
Gland Pharma Ltd - 543245 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fosun Pharma Industrial Pte Ltd
19 Jun 2024
Gland Pharma promoter Fosun divests 6% stake for Rs 1,754 cr via bulk deal
Fosun Pharma, one of the promoters of Gland Pharma, on Wednesday divested a 6 per cent stake for Rs 1,754 crore through an open market transaction. Chinese drug firm Fosun Pharma, through its arm Fosun Pharma Industrial Pte, offloaded the shares of Hyderabad-based Gland Pharma through a bulk deal on the BSE. According to the bulk deal data available on the BSE, Fosun Pharma Industrial Pte disposed of 99 lakh shares or a 6 per cent stake in Gland Pharma. The shares were sold at an average price of Rs 1,771.81 apiece, taking the deal size to Rs 1,754.09 crore. After the stake sale, Fosun Pharma's shareholding in Gland Pharma has declined to 51.86 per cent from 57.86 per cent. Meanwhile, UBS Principal Capital Asia picked up 8.25 lakh shares, amounting to a 0.5 per cent stake in Gland Pharma. The shares were purchased at an average price of Rs 1,771.05 per piece, taking the transaction value to Rs 146.11 crore. Details of the other buyers of Gland Pharma's shares could not be...
08 Jun 2024
Gland Pharma appoints incumbent MD & CEO Srinivas Sadu as Executive Chairman & CEO
Srinivas Sadu's career with Gland Pharma began in 2000; he will assume his new role on June 10, 2024
07 Jun 2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 41,200 equity shares under ESOP
07 Jun 2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Srinivas Sadu appointed as Executive Chairman and CEO of Gland Pharma Limited
07 Jun 2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Directorate
Completion of tenure of Mr. Yiu Kwan Stanley Lau, Chairman and Independent Director
07 Jun 2024
Gland Pharma Ltd - 543245 - Board Meeting Outcome for Outcome Of The Board Meeting Held On June 07, 2024
Outcome of the Board Meeting held on June 07, 2024
07 Jun 2024
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation regarding Schedule of Analyst/Investor Meet on June 10, 2024
